Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1

BACKGROUND: Hormone therapy, oral contraceptives, and tamoxifen increase the risk of thrombotic disease. These compounds also reduce plasma content of tissue factor pathway inhibitor-1 (TFPI), which is the physiological inhibitor of the tissue factor pathway of coagulation. The current aim was to st...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahm, Anders EA, Iversen, Nina, Birkenes, Baard, Ree, Anne Hansen, Sandset, Per Morten
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609184/
https://www.ncbi.nlm.nih.gov/pubmed/17029634
http://dx.doi.org/10.1186/1471-2261-6-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609184/
https://www.ncbi.nlm.nih.gov/pubmed/17029634
http://dx.doi.org/10.1186/1471-2261-6-40

Ejemplares similares